Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial - Vogel, V G; Costantino, J P; Wickerham, D L (JAMA, 2006)
, et al.